Xie Jian 4

What Happened

• Xie Jian, President and Chief Operating Officer of Fulgent Genetics, had 4,711 shares withheld to satisfy tax withholding obligations arising from the vesting of restricted stock units (RSUs). The shares were valued at $27.53 each, totaling $129,694. This transaction is coded F (tax withholding) — a routine reduction of shares to cover taxes, not an open-market sale driven by discretionary selling.

Key Details

• Transaction date: January 26, 2026; Filing date: January 28, 2026 (timely Form 4 filing).
• Price per share: $27.53; Shares withheld/disposed: 4,711; Total value: $129,694.
• Shares owned after the transaction: Not specified in the provided filing excerpt.
• Footnotes:
  • F1: Shares were withheld to satisfy tax obligations from RSUs assumed under the November 7, 2022 merger agreement; these awards were originally reported on a Form 4 filed November 9, 2022.
  • F2: Some securities are held by The Hsieh Family Dynasty Trust (dated Jan 27, 2010); Mr. Xie serves on the trust’s investment committee and disclaims beneficial interest except for any pecuniary interest.
• Transaction type: Tax withholding (code F), not an open-market discretionary sale.

Context

• Tax-withholding dispositions on RSU vesting are common and typically reflect tax obligations rather than a manager’s view of the company’s prospects. This should be viewed as a routine administrative transaction rather than a directional insider trade.